Nov 14, 2018
The results of a new clinical trial with ketamine were published in Nature’s Molecular Psychiatry journal. Researchers conducted a double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant...
Aug 25, 2018
The National Institute of Mental Health (NIMH) issued a highlight on ketamine for treating depression. The most commonly used antidepressants are largely variations on a theme; they increase the supply within synapses of a class of neurotransmitters believed to play a...
Aug 14, 2018
Researchers from the University of Minnesota and The Mayo Clinic found that ketamine caused an average decrease of 42% on the Children’s Depression Rating Scale(CDRS)—the most widely used rating scale in research trials for assessing the severity of depression and...
Aug 8, 2018
Researchers at Yale published a new study titled “Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital” in Clinical Psychiatry. In late 2014, Yale began providing ketamine as an off-label therapy on a...
Aug 6, 2018
CNN featured a segment on the use of ketamine for treating suicidal ideation–a novel, off-label use for ketamine that is currently being explored in human clinical trials. The segment featured Dr. Sanjay Gupta sharing the story of Alan Ferguson. Mr. Ferguson...
Jul 27, 2017
Neuropathic pain is notoriously difficult to treat. Patients are often treated as regular chronic pain patients and many resort to opioids to manage extreme levels of pain. Neuropathic pain can originate from infection, metabolic diseases, chemotherapy, trauma and...
Jul 24, 2017
Australian researchers completed the world’s first randomized control trial (RCT), assessing the efficacy and safety of ketamine as a treatment for depression in elderly patients. In this double-blind, controlled, multiple-crossover study with a 6-month follow-up, 16...
